Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Freedman

Showing results (111-120 of 165) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Colorectal cancer risk prediction tool for white men and women without known susceptibilityAndrew N Freedman, Martha L Slattery, Rachel Ballard-Barbash, et al.
Breast Cancer Research and Treatment|January 29, 2014
Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based studyH-T Tsai, C Isaacs, A Z Fu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2011
Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associationsMoniek van Zitteren, Jeroen B van der Net, Suman Kundu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2018
Super-resolution T2-weighted 4D MRI for image guided radiotherapyJoshua N Freedman, David J Collins, Oliver J Gurney-Champion, et al.
American Journal of Medical Genetics. Part A|June 10, 2003
US physicians' attitudes toward genetic testing for cancer susceptibilityA N Freedman, L Wideroff, L Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or olderAndrew N Freedman, Binbing Yu, Mitchell H Gail, et al.
JCO Precision Oncology|July 12, 2021
Oncologist-Reported Reasons for Not Ordering Multimarker Tumor Panels: Results From a Nationally Representative SurveyMegan C Roberts, Lisa P Spees, Andrew N Freedman, et al.
Cancer|October 7, 2015
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinomaSekwon Jang, Chaoyi Zheng, Huei-Ting Tsai, et al.
Patient Education and Counseling|March 22, 2020
Involving patients and their families in deciding to use next generation sequencing: Results from a nationally representative survey of U.S. oncologistsLisa P Spees, Megan C Roberts, Andrew N Freedman, et al.
Journal of the National Cancer Institute|November 2, 2019
Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related TreatmentsK Robin Yabroff, Jingxuan Zhao, Janet S de Moor, et al.
Pageof 17

Showing results (111-120 of 165) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2008
Colorectal cancer risk prediction tool for white men and women without known susceptibilityAndrew N Freedman, Martha L Slattery, Rachel Ballard-Barbash, et al.
Breast Cancer Research and Treatment|January 29, 2014
Risk of cardiovascular adverse events from trastuzumab (Herceptin(®)) in elderly persons with breast cancer: a population-based studyH-T Tsai, C Isaacs, A Z Fu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 8, 2011
Genome-based prediction of breast cancer risk in the general population: a modeling study based on meta-analyses of genetic associationsMoniek van Zitteren, Jeroen B van der Net, Suman Kundu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 7, 2018
Super-resolution T2-weighted 4D MRI for image guided radiotherapyJoshua N Freedman, David J Collins, Oliver J Gurney-Champion, et al.
American Journal of Medical Genetics. Part A|June 10, 2003
US physicians' attitudes toward genetic testing for cancer susceptibilityA N Freedman, L Wideroff, L Olson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2011
Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or olderAndrew N Freedman, Binbing Yu, Mitchell H Gail, et al.
JCO Precision Oncology|July 12, 2021
Oncologist-Reported Reasons for Not Ordering Multimarker Tumor Panels: Results From a Nationally Representative SurveyMegan C Roberts, Lisa P Spees, Andrew N Freedman, et al.
Cancer|October 7, 2015
Cardiovascular toxicity after antiangiogenic therapy in persons older than 65 years with advanced renal cell carcinomaSekwon Jang, Chaoyi Zheng, Huei-Ting Tsai, et al.
Patient Education and Counseling|March 22, 2020
Involving patients and their families in deciding to use next generation sequencing: Results from a nationally representative survey of U.S. oncologistsLisa P Spees, Megan C Roberts, Andrew N Freedman, et al.
Journal of the National Cancer Institute|November 2, 2019
Factors Associated With Oncologist Discussions of the Costs of Genomic Testing and Related TreatmentsK Robin Yabroff, Jingxuan Zhao, Janet S de Moor, et al.
Pageof 17